Human embryonic stem cells: genetic manipulation on the way to cardiac cell therapies.
about
Electroporation Knows No Boundaries: The Use of Electrostimulation for siRNA Delivery in Cells and TissuesISL1 protein transduction promotes cardiomyocyte differentiation from human embryonic stem cellsExtracellular matrix formation after transplantation of human embryonic stem cell-derived cardiomyocytes.Exogenous expression of human apoA-I enhances cardiac differentiation of pluripotent stem cells.Efficient, high-throughput transfection of human embryonic stem cellsTargeted genomic integration of a selectable floxed dual fluorescence reporter in human embryonic stem cells.Enhanced transfection efficiency of human embryonic stem cells by the incorporation of DNA liposomes in extracellular matrixHuman embryonic stem cells form functional thyroid folliclesCardiomyocytes derived from stem cells.Isolation and expansion of resident cardiac progenitor cells.Engineering human embryonic stem cell differentiation.Label-free separation of human embryonic stem cells and their cardiac derivatives using Raman spectroscopy.Cardiac stem cells and progenitors: developmental biology and therapeutic challenges.Comparison of Different Electroporation Parameters on Transfection Efficiency of Sheep Testicular Cells.Genetic engineering and stem cells: combinatorial approaches for cardiac cell therapyFast and efficient multitransgenic modification of human pluripotent stem cells.Allele-specific RNA interference rescues the long-QT syndrome phenotype in human-induced pluripotency stem cell cardiomyocytes.Differential gene expressions in atrial and ventricular myocytes: insights into the road of applying embryonic stem cell-derived cardiomyocytes for future therapies.Human pluripotent stem cell-based approaches for myocardial repair: from the electrophysiological perspective.In vitro uses of human pluripotent stem cell-derived cardiomyocytes.Ouabain facilitates cardiac differentiation of mouse embryonic stem cells through ERK1/2 pathwayEnhancement of cardiomyocyte differentiation from human embryonic stem cells.Distinct cardiogenic preferences of two human embryonic stem cell (hESC) lines are imprinted in their proteomes in the pluripotent stateEctopic expression of systemic RNA interference defective protein in embryonic stem cells.Evaluation of Multiple Biological Therapies for Ischemic Cardiac Disease.
P2860
Q26998879-376974FA-04BF-4A46-91C0-8399945C434FQ28485369-ED5BBBE7-F84C-4AC1-B8BB-A3F8F6F797E9Q33572148-AD42D89D-D6FA-4EFA-BA19-8307FF59912FQ33904083-39C5717B-AC60-490B-A32F-521D8A48193BQ34135224-616EB815-F237-4BDC-B95D-A3D3AD4BBA60Q34447692-4415931E-8DAC-45D0-9F99-ABC2292224A8Q35029331-62828AF6-DBC1-48C6-BD23-223167151E15Q35324259-5CD767F1-7809-484B-9BE1-F142DFAEF825Q36309565-C9CA8C25-33C3-4814-A4C9-E6B38A2D7C0EQ36691627-4A70B0BE-F1C6-4B9B-8445-7185680428B9Q37024709-BF454B70-79EC-4D27-BF38-DCB5846D00F2Q37121021-49082348-669F-41C2-8344-46A587619058Q37182776-5D0EA18C-9B45-469B-B779-27A117EF8E49Q37232036-246E99F4-EC4B-44B0-BF5C-C424E53C390CQ37294352-C6BA5B29-D40D-4F32-8AB7-62262592037EQ37710740-48D38B54-12A5-4287-8EC7-E5C8FD82365FQ37711518-17F72038-59AB-4FDF-8CED-9D113AFDDAA9Q37789112-440BFF14-ED64-4272-91B0-98A6367BF08DQ37924272-1210D32E-A01E-42ED-BA52-9174F04A3738Q38013733-86A0660B-BA07-43E8-AC2E-0F277A3CC722Q39027980-9AE1BF14-28C6-4FED-A9D5-EBC166600E67Q39685694-E351D426-B18F-41D1-8A99-282F6A4F849DQ39978595-649F737D-F593-4BAB-A816-225D3DD1A9A8Q40145763-3C50DA55-7EEC-44DC-A4DC-8353C94DD28BQ53104041-9B5D62AA-4C63-48C0-A257-3CD4CFB0066A
P2860
Human embryonic stem cells: genetic manipulation on the way to cardiac cell therapies.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Human embryonic stem cells: genetic manipulation on the way to cardiac cell therapies.
@ast
Human embryonic stem cells: genetic manipulation on the way to cardiac cell therapies.
@en
type
label
Human embryonic stem cells: genetic manipulation on the way to cardiac cell therapies.
@ast
Human embryonic stem cells: genetic manipulation on the way to cardiac cell therapies.
@en
prefLabel
Human embryonic stem cells: genetic manipulation on the way to cardiac cell therapies.
@ast
Human embryonic stem cells: genetic manipulation on the way to cardiac cell therapies.
@en
P2093
P1476
Human embryonic stem cells: genetic manipulation on the way to cardiac cell therapies.
@en
P2093
Dorien Ward
Jennifer C Moore
Leon L Tertoolen
Linda W van Laake
Robert Passier
Ronald A Li
Stefan R Braam
Suk-Ying Tsang
P304
P356
10.1016/J.REPROTOX.2005.04.012
P577
2005-09-01T00:00:00Z